re: cce You only have to look at the chart to realise that the impact of FDA approval and other positive news has not been factoired into the price
"We continue to believe that CCE will provide an attractive speculative investment however the stock will be exposed to any delays the company experiences in generating sales revenues from both its CellSpray and ReCell products."
Hell - I wonder what these fellows say about biotechs that have not developed their products to tangible sales
- Forums
- ASX - By Stock
- CCE
- featured in huntley again
featured in huntley again, page-19
Featured News
Add CCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $15.01M |
Open | High | Low | Value | Volume |
4.4¢ | 4.5¢ | 4.1¢ | $3.634K | 85.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 203009 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 50247 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 203009 | 0.041 |
7 | 900158 | 0.040 |
3 | 204094 | 0.039 |
9 | 611200 | 0.038 |
2 | 130000 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 50247 | 2 |
0.046 | 200000 | 1 |
0.047 | 21297 | 1 |
0.048 | 50000 | 1 |
0.049 | 270428 | 2 |
Last trade - 15.46pm 10/07/2024 (20 minute delay) ? |
Featured News
CCE (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online